This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pfizer Inc (PFE)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 9.17B 22.07B 14.60B 10.05B
Operating Gains/Losses -250.00M -10.60B -7.12B -1.67B
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 148.00M 940.00M 275.00M -66.00M
(Increase) Decrease in Inventories 175.00M -538.00M -631.00M 1.08B
(Increase) Decrease In Other Current Assets 0.00 0.00 83.00M 582.00M
(Decrease) Increase In Payables 297.00M 382.00M 579.00M 1.15B
(Decrease) Increase In Other Current Liabilities 0.00 0.00 -2.25B -18.00M
(Increase) Decrease In Other Working Capital 803.00M -4.18B 0.00 0.00
Other Non-Cash Items 688.00M 1.57B 1.71B -83.00M
Net Cash From Continuing Operations 16.88B 17.77B 17.05B 20.24B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 16.88B 17.77B 17.05B 20.24B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 47.37B 41.13B 25.30B 25.05B
Purchases of Property, Plant & Equipment -1.58B -1.47B -1.33B -1.66B
Acquisitions -195.00M -15.00M 10.80B -906.00M
Purchases of Short-Term Investments -50.95B -42.76B -24.02B -18.43B
Other Cash from Investing Activities 4.28B -4.05B 1.55B 60.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -5.65B -10.62B 6.15B 2.20B
Issuance of Debt 4.50B 10.94B 8.00B 12.81B
Cash Used for Financing Activities
Issuance of Capital Stock 1.00B 1.75B 0.00 0.00
Repayment of Long-Term Debt -2.11B -8.38B -1.52B -10.81B
Repurchase of Capital Stock -5.00B -16.29B -8.23B -9.00B
Payment of Cash Dividends -6.61B -6.58B -6.53B -6.23B
Other Financing Charges, Net -1.77B 3.58B -7.72B -7.37B
Net Cash From Financing Activities -9.99B -14.97B -16.00B -20.61B
Effect of Exchange Rate Changes -83.00M -63.00M -2.00M -29.00M
Net Change in Cash & Cash Equivalents 1.16B -7.90B 7.21B 1.80B
PFE News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for PFE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 9 8 8
Moderate Buy 1 1 0 0
Hold 3 2 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1

PFE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs